This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ernst & Young (2007) Beyond Borders – Global Biotechnology Report 2007. EYGM Limited
Farid SS (2007) Process economics of industrial monoclonal antibody manufacture. J Chromatogr B 848:8–18
Fox JL (2003) Puzzling industry response to ProdiGene fiasco. Nature Biotechnology 21:3–4
Knäblein J (2005) Plant-based expression of biopharmaceuticals. In: Meyers R (ed) Encyclopedia of molecular cell biology and molecular medicine. Wiley-VCH, Weinheim, pp 385–410
Lawrence S (2005) Biotech drug market steadily expands. Nat Biotechnol 23:1466
Lawrence S (2007) Billion dollar babies – biotech drugs as blockbusters. Nat Biotechnol 25:380–382
Nykiforuk CL, Boothe JG, Markley NA, Moloney MM (2006) Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol J 4:77–85
Pavlou AK, Reichert JM (2004) Recombinant protein therapeutics – success rates, market trends and values to 2010. Nature Biotechnology 22:1513–1519
Pavlou AK, Belsey MJ (2005) The therapeutic antibodies market to 2008. European Journal of Pharmaceutics and Biopharmaceutics 59:389–396
Sauter A (2005) Grüne Gentechnik – transgene Pflanzen der 2. und 3. Generation. Arbeitsbericht des Büros für Technikfolgen-Abschätzung beim Deutschen Bun destag, No. 104
Spök A (2007) Molecular farming on the rise – GMO regulators still walking a tightrope. Trends in Biotechnology 25:75–82
Walsh G (2006) Biopharmaceutical benchmarks 2006. Nature Biotechnology 24:769–776
http://www.who.int/diabetes/facts/en/diabcare0504.pdf (July 2008)
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes. Diabetes Care 27:1047–1053
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rehbinder, E. et al. (2009). Introduction. In: Pharming. Ethics of Science and Technology Assessment, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-85793-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-540-85793-8_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-85792-1
Online ISBN: 978-3-540-85793-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)